Orliaguet G, Mélik Parsadaniantz S, Lenoir V, Duval P, Kerdelhué B
Laboratoire de Neurobiologie de la Reproduction, CNRS-INRA, Jouy-en-Josas, France.
J Neurosci Res. 1995 Oct 1;42(2):236-41. doi: 10.1002/jnr.490420211.
To clarify the controversy concerning the role of catecholaminergic systems in regulating hypothalamic corticotropin-releasing factor (CRF) secretion, we assessed the direct effects of norepinephrine and epinephrine, alone and in association with mixed alpha and beta antagonists on hypothalamic CRF secretion. An in vitro rat mediobasal hypothalamus perifusion system was used, in which CRF secretion from a single explant was evaluated by a specific radioimmunoassay. We found that norepinephrine stimulated CRF secretion, with peak effects at 10(-8) M concentration, whereas epinephrine had no effect on CRF secretion. The effect of norepinephrine was antagonised by the mixed alpha antagonist phentolamine and by the mixed beta antagonist propranolol. We conclude that norepinephrine, but not epinephrine, stimulate hypothamic CRF secretion via alpha and beta receptors. The data support the idea that the central noradrenergic systems are excitatory upon CRF-41 secretion when acting directly at the hypothalamic level.
为了阐明儿茶酚胺能系统在调节下丘脑促肾上腺皮质激素释放因子(CRF)分泌中的作用这一争议,我们评估了去甲肾上腺素和肾上腺素单独以及与α和β混合拮抗剂联合使用对下丘脑CRF分泌的直接影响。使用了体外大鼠中基底下丘脑灌流系统,通过特定的放射免疫测定法评估单个外植体的CRF分泌。我们发现去甲肾上腺素刺激CRF分泌,在10^(-8) M浓度时达到峰值效应,而肾上腺素对CRF分泌没有影响。去甲肾上腺素的作用被α混合拮抗剂酚妥拉明和β混合拮抗剂普萘洛尔拮抗。我们得出结论,去甲肾上腺素而非肾上腺素通过α和β受体刺激下丘脑CRF分泌。这些数据支持了这样一种观点,即中枢去甲肾上腺素能系统在直接作用于下丘脑水平时对CRF-41分泌具有兴奋性。